title: Autoantibodies induced by chimeric cytokine-HIV envelope glycoprotein immunogens.
abstract: Cytokines are often used as adjuvants to increase the immunogenicity of vaccines because they can improve the immune response and/or direct it into a desired direction. As an alternative to codelivering Ags and cytokines separately, they can be fused into a composite protein, with the advantage that both moieties act on the same immune cells. The HIV-1 envelope glycoprotein (Env) spike, located on the outside of virus particles and the only relevant protein for the induction of neutralizing Abs, is poorly immunogenic. The induction of anti-Env Abs can be improved by coupling Env proteins to costimulatory molecules such as a proliferation inducing ligand (APRIL). In this study, we evaluated the immunogenicity of chimeric molecules containing uncleaved Env gp140 fused to the species-matched cytokines IL-21 or GM-CSF in rabbits and mice. Each cytokine was either fused to the C terminus of Env or embedded within Env at the position of the variable loops 1 and 2. The cytokine components of the chimeric Env-GM-CSF and Env-IL-21 molecules were functional in vitro, but none of the Env-cytokine fusion proteins resulted in improved Ab responses in vivo. Both the Env-GM-CSF and the Env-IL-21 molecules induced strong anticytokine Ab responses in both test species. These autoimmune responses were independent of the location of the cytokine in the chimeric Env molecules in that they were induced by cytokines inserted within the variable loops 1 and 2 of Env or fused to its C terminus. The induction of undesired autoimmune responses should be considered when using cytokines as costimulatory molecules in fusion proteins.
authors.affiliation: Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam, Academic Medical Center, University of Amsterdam, 1100 DE Amsterdam, The Netherlands.
authors.forename: Gözde
authors.initials: G
authors.lastname: Isik
authors.forename: Thijs
authors.initials: T
authors.lastname: van Montfort
authors.forename: Nancy P Y
authors.initials: NP
authors.lastname: Chung
authors.forename: John P
authors.initials: JP
authors.lastname: Moore
authors.forename: Rogier W
authors.initials: RW
authors.lastname: Sanders
mesh_terms: D000818:Animals; D001323:Autoantibodies / Q000276:immunology*; D001327:Autoimmune Diseases / Q000139:chemically induced / Q000235:genetics / Q000276:immunology / Q000473:pathology; D045744:Cell Line, Tumor; D015497:HIV-1 / Q000235:genetics / Q000276:immunology; D006801:Humans; D007378:Interleukins / Q000009:adverse effects / Q000235:genetics / Q000276:immunology / Q000494:pharmacology; D051379:Mice; D017433:Protein Structure, Secondary; D011817:Rabbits; D011993:Recombinant Fusion Proteins / Q000009:adverse effects / Q000235:genetics / Q000276:immunology / Q000494:pharmacology; D054299:env Gene Products, Human Immunodeficiency Virus / Q000009:adverse effects / Q000235:genetics / Q000276:immunology / Q000494:pharmacology; D000098546:Interleukin-21
chemical_list: D001323:Autoantibodies; D007378:Interleukins; D011993:Recombinant Fusion Proteins; D054299:env Gene Products, Human Immunodeficiency Virus; D000098546:Interleukin-21
references.citation: Rheumatol Int. 1999;18(4):141-5
references.pmid: 10220834
references.citation: J Immunol. 2012 Dec 1;189(11):5257-65
references.pmid: 23100517
references.citation: J Virol. 2002 Jul;76(14):7306-21
references.pmid: 12072529
references.citation: J Virol. 2010 Feb;84(3):1439-52
references.pmid: 19939925
references.citation: Nature. 2011 Nov 23;480(7377):336-43
references.pmid: 22113616
references.citation: J Virol. 2000 Sep;74(18):8358-67
references.pmid: 10954535
references.citation: Vaccine. 2009 Jan 7;27(2):243-9
references.pmid: 18996425
references.citation: Expert Opin Biol Ther. 2008 May;8(5):609-32
references.pmid: 18407765
references.citation: Nat Immunol. 2004 Mar;5(3):233-6
references.pmid: 14985706
references.citation: Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18256-61
references.pmid: 24145402
references.citation: Arthritis Rheum. 2002 Sep;46(9):2384-91
references.pmid: 12355486
references.citation: J Immunol. 2006 Apr 1;176(7):3931-41
references.pmid: 16547227
references.citation: Thorax. 2006 Jun;61(6):528-34
references.pmid: 16517574
references.citation: J Clin Oncol. 2008 Apr 20;26(12):2034-9
references.pmid: 18347008
references.citation: J Virol. 2009 Jan;83(1):368-83
references.pmid: 18922866
references.citation: J Virol. 2002 Mar;76(6):2606-16
references.pmid: 11861826
references.citation: Science. 2011 Nov 25;334(6059):1097-103
references.pmid: 21998254
references.citation: Vaccine. 2004 Mar 12;22(9-10):1124-30
references.pmid: 15003639
references.citation: J Virol. 2002 Sep;76(17):8875-89
references.pmid: 12163607
references.citation: J Biol Chem. 2010 Nov 19;285(47):36456-70
references.pmid: 20826824
references.citation: Immunity. 2003 Nov;19(5):679-88
references.pmid: 14614855
references.citation: J Interferon Cytokine Res. 1997 Jul;17 Suppl 1:S5-8
references.pmid: 9241609
references.citation: PLoS Pathog. 2007 Nov;3(11):e169
references.pmid: 17983270
references.citation: Science. 2013 Dec 20;342(6165):1484-90
references.pmid: 24179160
references.citation: J Virol. 2003 Feb;77(4):2310-20
references.pmid: 12551968
references.citation: J Immunol. 2003 Mar 1;170(5):2496-507
references.pmid: 12594275
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3396-401
references.pmid: 17360657
references.citation: Cancer Immunol Immunother. 2002 Oct;51(8):449-60
references.pmid: 12202906
references.citation: Nat Immunol. 2009 Jun;10(6):573-8
references.pmid: 19448659
references.citation: J Virol. 2000 Jan;74(2):627-43
references.pmid: 10623724
references.citation: Retrovirology. 2011 Jun 20;8:48
references.pmid: 21689404
references.citation: Virology. 2010 Jun 5;401(2):236-47
references.pmid: 20304457
references.citation: J Virol. 2006 Mar;80(5):2515-28
references.pmid: 16474158
references.citation: Vaccine. 2006 Apr 12;24(16):3298-308
references.pmid: 16464521
references.citation: J Virol. 2012 Mar;86(5):2488-500
references.pmid: 22205734
references.citation: J Virol. 2001 Jun;75(12):5526-40
references.pmid: 11356960
references.citation: Gynecol Oncol. 2006 Aug;102(2):244-51
references.pmid: 16434085
references.citation: PLoS Pathog. 2013 Sep;9(9):e1003618
references.pmid: 24068931
references.citation: J Virol. 2003 Oct;77(20):10850-61
references.pmid: 14512535
references.citation: PLoS One. 2013 Jun 24;8(6):e67309
references.pmid: 23826263
references.citation: Science. 2013 Dec 20;342(6165):1477-83
references.pmid: 24179159
references.citation: Clin Cancer Res. 2007 Jun 15;13(12):3630-6
references.pmid: 17575227
references.citation: J Infect Dis. 2005 Mar 1;191(5):666-77
references.pmid: 15688279
references.citation: J Interferon Res. 1994 Aug;14(4):157-8
references.pmid: 7822860
references.citation: J Virol. 2013 Nov;87(21):11462-75
references.pmid: 23966389
references.citation: Lancet. 1983 Jan 15;1(8316):81-4
references.pmid: 6129455
references.citation: J Immunol. 2011 May 15;186(10):5527-32
references.pmid: 21540457
references.citation: PLoS One. 2013;8(4):e60126
references.pmid: 23565193
references.citation: Blood. 1998 Mar 15;91(6):2054-61
references.pmid: 9490690
references.citation: AIDS Res Hum Retroviruses. 2012 Feb;28(2):206-14
references.pmid: 21793733
references.citation: Nature. 2003 Mar 20;422(6929):307-12
references.pmid: 12646921
references.citation: J Infect Dis. 1989 Dec;160(6):960-9
references.pmid: 2555423
references.citation: Ann Oncol. 2007 Feb;18(2):226-32
references.pmid: 17116643
references.citation: J Infect Dis. 2001 Dec 1;184(11):1423-30
references.pmid: 11709784
references.citation: J Virol. 2011 Jun;85(12):5825-39
references.pmid: 21471242
references.citation: J Cell Physiol. 1997 Nov;173(2):219-26
references.pmid: 9365526
references.citation: J Virol. 2005 Aug;79(16):10108-25
references.pmid: 16051804
references.citation: J Virol. 1997 Dec;71(12):9808-12
references.pmid: 9371651
references.citation: Clin Immunol Immunopathol. 1998 Sep;88(3):241-8
references.pmid: 9743610
references.citation: J Cell Physiol. 1989 Aug;140(2):323-34
references.pmid: 2663885
references.citation: Vaccine. 2005 Jun 10;23(30):3984-90
references.pmid: 15917120
references.citation: Proc Natl Acad Sci U S A. 1992 May 15;89(10):4447-51
references.pmid: 1316609
references.citation: Chem Immunol. 1997;65:18-56
references.pmid: 9018871
references.citation: Nephrol Dial Transplant. 2003 Nov;18 Suppl 8:viii37-41
references.pmid: 14608000
references.citation: Scand J Immunol. 1993 Nov;38(5):472-6
references.pmid: 8235450
references.citation: Immunol Today. 1995 May;16(5):216-20
references.pmid: 7779250
references.citation: Biotherapy. 1997;10(1):29-37
references.pmid: 9261548
references.citation: J Clin Invest. 2004 Nov;114(9):1241-4
references.pmid: 15520855
references.citation: J Biol Chem. 2011 Jun 24;286(25):22250-61
references.pmid: 21515681
references.citation: Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2726-30
references.pmid: 2011582
references.citation: J Leukoc Biol. 2011 Jul;90(1):205-14
references.pmid: 21474552
references.citation: J Exp Med. 2005 Jan 3;201(1):139-48
references.pmid: 15630141
references.citation: J Immunol. 1995 Apr 1;154(7):3105-17
references.pmid: 7897201
references.citation: Ann Rheum Dis. 2002 Jul;61(7):598-602
references.pmid: 12079899
references.citation: Immunol Today. 1990 May;11(5):167-9
references.pmid: 2186750
references.citation: Infect Immun. 2002 Oct;70(10):5589-95
references.pmid: 12228286
references.citation: Discov Med. 2010 Jul;10(50):52-60
references.pmid: 20670599
references.citation: Nat Med. 1997 Apr;3(4):366-7
references.pmid: 9095159